{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:48:12Z","timestamp":1747154892248,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.anai.2024.05.022","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:30:42Z","timestamp":1718299842000},"page":"278-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Oral food immunotherapy in patients with atopic dermatitis"],"prefix":"10.1016","volume":"133","author":[{"given":"Gilbert T.","family":"Chua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9800-0951","authenticated-orcid":false,"given":"Douglas P.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus S.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2024.05.022_bib0001","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaci.2021.05.035","article-title":"The airway as a route of sensitization to peanut: an update to the dual allergen exposure hypothesis","volume":"148","author":"Kulis","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2024.05.022_bib0002","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/all.14304","article-title":"Epicutaneous sensitization in the development of food allergy: what is the evidence and how can this be prevented?","volume":"75","author":"Brough","year":"2020","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.anai.2024.05.022_bib0003","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N Engl J Med"},{"issue":"10344","key":"10.1016\/j.anai.2024.05.022_bib0004","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/S0140-6736(22)00687-0","article-title":"Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): a factorial, multicentre, cluster-randomised trial","volume":"399","author":"Skjerven","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.anai.2024.05.022_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2022.9224","article-title":"Association between earlier introduction of peanut and prevalence of peanut allergy in infants in Australia","volume":"328","author":"Soriano","year":"2022","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.anai.2024.05.022_bib0006","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.jaip.2022.05.040","article-title":"The case for prompt salvage infant peanut oral immunotherapy following failed primary prevention","volume":"10","author":"Chua","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2024.05.022_bib0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaci.2021.12.795","article-title":"Changes in Australian food anaphylaxis admission rates following introduction of updated allergy prevention guidelines","volume":"150","author":"Mullins","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2024.05.022_bib0008","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.jaip.2022.06.044","article-title":"Dietary elimination for the treatment of atopic dermatitis: a systematic review and meta-analysis","volume":"10","author":"Oykhman","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2024.05.022_bib0009","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jaci.2019.09.036","article-title":"Defining challenge-proven coexistent nut and sesame seed allergy: a prospective multicenter European study","volume":"145","author":"Brough","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.022_bib0010","article-title":"Real-world safety and effectiveness analysis of low-dose preschool sesame oral immunotherapy","volume":"3","author":"Chua","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"4","key":"10.1016\/j.anai.2024.05.022_bib0011","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jaip.2023.01.031","article-title":"Real-world safety analysis of preschool tree nut oral immunotherapy","volume":"11","author":"Erdle","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2024.05.022_bib0012","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.05.022_bib0013","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaip.2020.10.045","article-title":"First real-world effectiveness analysis of preschool peanut oral immunotherapy","volume":"9","author":"Soller","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2024.05.022_bib0014","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaip.2021.12.009","article-title":"Real-world peanut OIT in infants may be safer than non-infant preschool OIT and equally effective","volume":"10","author":"Soller","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10322","key":"10.1016\/j.anai.2024.05.022_bib0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.anai.2024.05.022_bib0016","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2024.05.022_bib0017","article-title":"Oral immunotherapy for peanut allergy in children 1 to less than 4 years of age","volume":"2","author":"Toit","year":"2023","journal-title":"NEJM Evid"},{"issue":"5","key":"10.1016\/j.anai.2024.05.022_bib0018","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.anai.2022.03.004","article-title":"Optimizing topical management of atopic dermatitis","volume":"128","author":"Butala","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2024.05.022_bib0019","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jaip.2022.11.015","article-title":"How we manage gastrointestinal symptoms during oral immunotherapy through a shared decision-making process\u2014a practical guide for the community practitioner","volume":"11","author":"Chua","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.05.022_bib0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations","volume":"132","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.022_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-10-1","article-title":"Safety and feasibility of oral immunotherapy to multiple allergens for food allergy","volume":"10","author":"B\u00e9gin","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2024.05.022_bib0022","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/j.jaip.2021.06.008","article-title":"Atypical eczematous lesions triggered by oral immunotherapy in a patient with a familial history of psoriasis","volume":"9","author":"Frugier","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2024.05.022_bib0023","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaip.2018.10.048","article-title":"Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy","volume":"7","author":"Blumchen","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2024.05.022_bib0024","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaip.2015.01.017","article-title":"Oral immunotherapy for egg allergy: a double-blind placebo-controlled study, with postdesensitization follow-up","volume":"3","author":"Caminiti","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2024.05.022_bib0025","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.12905","article-title":"Oral immunotherapy with low allergenic hydrolysed egg in egg allergic children","volume":"71","author":"Giavi","year":"2016","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2024.05.022_bib0026","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jaip.2019.02.007","article-title":"Adverse events in oral immunotherapy for the desensitization of Cow's milk allergy in children: a randomized controlled trial","volume":"7","author":"De Schryver","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.05.022_bib0027","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.anai.2020.05.031","article-title":"Shared decision-making in the care of a patient with food allergy","volume":"125","author":"Greenhawt","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10356","key":"10.1016\/j.anai.2024.05.022_bib0028","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0140-6736(22)01539-2","article-title":"Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"400","author":"Paller","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.anai.2024.05.022_bib0029","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.anai.2022.12.014","article-title":"Clinical guidance for the use of dupilumab in eosinophilic esophagitis: a yardstick","volume":"130","author":"Aceves","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"24","key":"10.1016\/j.anai.2024.05.022_bib0030","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa2106567","article-title":"Dupilumab in children with uncontrolled moderate-to-severe asthma","volume":"385","author":"Bacharier","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2024.05.022_bib0031","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaip.2018.07.027","article-title":"Dupilumab for treatment of food allergy","volume":"7","author":"Rial","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2024.05.022_bib0032","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/cea.13897","article-title":"The use of biologics in food allergy","volume":"51","author":"Fiocchi","year":"2021","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2024.05.022_bib0033","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaip.2023.11.032","article-title":"The role of biologics in the treatment of food allergy","volume":"12","author":"Sindher","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.05.022_bib0034","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/all.15591","article-title":"Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients","volume":"78","author":"Spekhorst","year":"2023","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.anai.2024.05.022_bib0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2024.05.022_bib0036","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jaci.2016.05.038","article-title":"Efficacy of omalizumab in patients with atopic dermatitis: a systematic review and meta-analysis","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624003454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624003454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T02:39:51Z","timestamp":1729564791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624003454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1081120624003454"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.05.022","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral food immunotherapy in patients with atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}